| Page 1058 | Kisaco Research
 

Sou Miyake

Director of Investment & Business Development
Corundum Systems Biology

Sou Miyake

Director of Investment & Business Development
Corundum Systems Biology

Sou Miyake

Director of Investment & Business Development
Corundum Systems Biology
 

Mary Poor

Vice President of Quality and CMC
Siolta Therapeutics

Mary Poor

Vice President of Quality and CMC
Siolta Therapeutics

Mary Poor

Vice President of Quality and CMC
Siolta Therapeutics
 

Sabine Hazan

Chief Executive Officer
ProgenaBiome

Sabine Hazan

Chief Executive Officer
ProgenaBiome

Sabine Hazan

Chief Executive Officer
ProgenaBiome
 

Joe Trebley

Chief Executive Officer
Scioto Biosciences, Inc

Joe Trebley

Chief Executive Officer
Scioto Biosciences, Inc

Joe Trebley

Chief Executive Officer
Scioto Biosciences, Inc
 

Stacy Burns Gurdish

President
List Labs

Stacy Burns Gurdish

President
List Labs

Stacy Burns Gurdish

President
List Labs
 

Felix Faupel

Chief Commercial Officer
Bacthera

Felix Faupel

Chief Commercial Officer
Bacthera

Felix Faupel

Chief Commercial Officer
Bacthera
 

Nikole Kimes

Chief Executive Officer
Siolta Therapeutics

Nikole Kimes

Chief Executive Officer
Siolta Therapeutics

Nikole Kimes

Chief Executive Officer
Siolta Therapeutics
 

Tirthankar Lahiri

SVP, Data & In-Memory Technologies
Oracle

Tirthankar Lahiri is Vice President of the Data and In-Memory Technologies group for Oracle Database and is responsible for the Oracle Database Engine (including Database In-Memory, Data and Indexes, Space Management, Transactions, and the Database File System), the Oracle TimesTen In-Memory Database, and Oracle NoSQLDB.

Tirthankar Lahiri

SVP, Data & In-Memory Technologies
Oracle

Tirthankar Lahiri

SVP, Data & In-Memory Technologies
Oracle

Tirthankar Lahiri is Vice President of the Data and In-Memory Technologies group for Oracle Database and is responsible for the Oracle Database Engine (including Database In-Memory, Data and Indexes, Space Management, Transactions, and the Database File System), the Oracle TimesTen In-Memory Database, and Oracle NoSQLDB. Tirthankar has 22 years of experience in the Database industry and has worked extensively in a variety of areas including Manageability, Performance, Scalability, High Availability, Caching, Distributed Concurrency Control, In-Memory Data Management, NoSQL architectures, etc. He has 27 issued and has several pending patents in these areas. Tirthankar has a B.Tech in Computer Science from the Indian Institute of Technology (Kharagpur) and an MS in Electrical Engineering from Stanford University.

 

Mike Sandoval

Chief Technology Officer
Disruption Labs

Mike has a MS in pharmaceutical sciences from University of Texas at Austin with 14+ years in drug development funding, execution and portfolio strategies. Mike served as President and CEO of XEO Pharmaceuticals, a Contract Research Organization (CRO) helping drug startups and 503A pharmacies support early stage R&D and IND-enabling analytical programs. At Xeris Pharma (NASDAQ (XERS)) Mike led R&D operations & development of novel injectable drug products. He’s named inventor on several drug delivery patents and published 10+ scientific papers.

Mike Sandoval

Chief Technology Officer
Disruption Labs

Mike Sandoval

Chief Technology Officer
Disruption Labs

Mike has a MS in pharmaceutical sciences from University of Texas at Austin with 14+ years in drug development funding, execution and portfolio strategies. Mike served as President and CEO of XEO Pharmaceuticals, a Contract Research Organization (CRO) helping drug startups and 503A pharmacies support early stage R&D and IND-enabling analytical programs. At Xeris Pharma (NASDAQ (XERS)) Mike led R&D operations & development of novel injectable drug products. He’s named inventor on several drug delivery patents and published 10+ scientific papers. He is co-inventor of Disruption Labs’ lipid encapsulation technologies and leads commercial application at Santé Labs by managing tech transfer and commercial scale manufacturing.